Science in Dyslipidemia Disease

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

ODYSSEY Outcomes

NEJM Odyssey Outcomes

Odyssey Outcomes - Mortality

Odyssey Outcomes - CABG Results

Odyssey Outcomes - PVD Results

Odyssey Outcomes - Elderly Patients Results

Odyssey Outcomes - DM sub-analysis

ESC/EAS 2019 International Guidelines

Odyssey Outcomes - Total Events Results

Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - PVD Sub-analysis

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress
SEE EVERYTHING

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

Atherosclerosis: Identifying risks and improving outcomes

Improving Lipid Management for Patients Post-ACS

Lipid Management in Patients with ACS/ASCVD

EAS guidance regarding combining lipid-modifying therapy

Identifying and Treating Patients with High Lipidaemia Risk Post-ACS

Lp(a) and PCSK9 inhibition in nominally controlled LDL-C

The Role of the Patient in Achieving LDL-C Target

Overview of Adherence Data with LLT Highlighting The Most Recent Data With PCSK9i

Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?
SEE EVERYTHING

Events

Stay up to date and register for the latest events and view webinar recordings.

24:30

Dyslipidemia Webinars: Optimizing Dyslipidemia management​

Dyslipidemia Webisodes: Mortality data with Prof. Tunon

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management
SEE EVERYTHING